During the last session, Teladoc Health Inc. (NYSE:TDOC)’s traded shares were 5.03 million, with the beta value of the company hitting 0.80. At the end of the trading day, the stock’s price was $37.46, reflecting an intraday loss of -2.70% or -$1.04. The 52-week high for the TDOC share is $156.82, that puts it down -318.63 from that peak though still a striking 26.91% gain since the share price plummeted to a 52-week low of $27.38. The company’s market capitalization is $7.12B, and the average intraday trading volume over the past 10 days was 7.77 million shares, and the average trade volume was 6.61 million shares over the past three months.
Teladoc Health Inc. (TDOC) received a consensus recommendation of a Hold from analysts. That translates to a mean rating of 2.60. TDOC has a Sell rating from 0 analyst(s) out of 28 analysts who have looked at this stock. 24 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.55.
Teladoc Health Inc. (NYSE:TDOC) trade information
Teladoc Health Inc. (TDOC) registered a -2.70% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -2.70% in intraday trading to $37.46 this Thursday, 08/04/22, hitting a weekly high. The stock’s 5-day price performance is 5.22%, and it has moved by -3.48% in 30 days. Based on these gigs, the overall price performance for the year is -74.98%. The short interest in Teladoc Health Inc. (NYSE:TDOC) is 33.3 million shares and it means that shorts have 6.24 day(s) to cover.
The consensus price target of analysts on Wall Street is $37.83, which implies an increase of 0.98% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $28.00 and $55.00 respectively. As a result, TDOC is trading at a discount of -46.82% off the target high and 25.25% off the low.
Teladoc Health Inc. (TDOC) estimates and forecasts
Statistics show that Teladoc Health Inc. has underperformed its competitors in share price, compared to the industry in which it operates. Teladoc Health Inc. (TDOC) shares have gone down -51.28% during the last six months, with a year-to-date growth rate less than the industry average at -4,524.06% against 0.50. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to shrink -3.80% this quarter and then drop -557.10% in the quarter after that. In the rating firms’ projections, revenue will increase 18.70% compared to the previous financial year.
Revenue for the current quarter is expected to be $609.02 million as predicted by 22 analyst(s). Meanwhile, a consensus of 22 analyst(s) estimates revenue growth to $641.26 million by the end of Dec 2022.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -9.30%. While earnings are projected to return 49.00% in 2022.
Teladoc Health Inc. is due to release its next quarterly earnings between April 26 and May 02. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Teladoc Health Inc. (NYSE:TDOC)’s Major holders
Teladoc Health Inc. insiders own 1.29% of total outstanding shares while institutional holders control 82.26%, with the float percentage being 83.33%. ARK Investment Management, LLC is the largest shareholder of the company, while 971 institutions own stock in it. As of Jun 29, 2022, the company held over 20.29 million shares (or 12.59% of all shares), a total value of $673.96 million in shares.
The next largest institutional holding, with 13.24 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 8.21% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $954.87 million.
Also, the Mutual Funds coming in first place with the largest holdings of Teladoc Health Inc. (TDOC) shares are ARK ETF Tr-ARK Innovation ETF and Vanguard Total Stock Market Index Fund. Data provided on Jun 29, 2022 indicates that ARK ETF Tr-ARK Innovation ETF owns about 11.11 million shares. This amounts to just over 6.89 percent of the company’s overall shares, with a $369.01 million market value. The same data shows that the other fund manager holds slightly less at 4.18 million, or about 2.59% of the stock, which is worth about $301.55 million.